Global Pediatric Development of Drugs, Biologics, and Medical Devices
xii
Rishi Mehta, RAC
Senior Regulatory Affairs Specialist
Medtronic Canada ULC
Canada
Chapter 5
Azzurra Ravizza, MSc
Director, Global Regulatory Affairs
Pfizer R&D
US
Chapter 9
Kathrin Schalper, PhD, RAC
Executive Director, Regulatory Affairs
Avalo Therapeutics
US
Chapters 3 and 11
Jing Zhou, MS
Manager, Regulatory CMC
Roivant Sciences
US
Chapter 14
RAPS also would like to recognize the work of
the following subject matter experts who volun-
teered their time to review and provide valuable
feedback to the chapter authors.
Savita Bhalla
Senior Specialist Regulatory Affairs
Abbott
US
Chapter 4
Jocelyn Jennings, MS, RAC (US, Drugs,
Devices)
Vice President, Regulatory Affairs
Mycovia Pharmaceuticals, Inc.
US
All Chapters
Shruti Kalra
Director, Global Regulatory Affairs Oncology
Merck Pharmaceuticals
US
Chapter 2
Megha Mathur
Regulatory Affairs Specialist
Medtronic
US
Chapter 5
Linda McBride, RPh, RAC
Regulatory and Compliance Consultant
US
All Chapters
Emma O’Brien
Manager Regulatory Affairs
Theratechnologies Inc.
Ireland
Chapter 7
Azzurra Ravizza, MSc
Director, Global Regulatory Affairs
Pfizer R&D
US
Chapters 7 and 8
Charles Tam, MBA
Senior Manager, Regulatory Affairs, Intelligence,
and Governance
Edwards Lifesciences (Canada) Inc.
Canada
Chapter 5